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ABSTRACT  
Literature evidence indicates that changes of neurosteroids may be involved in the pathophysiology 
of Multiple Sclerosis (MS). The present study assessed if changes of neurosteroidogenesis also 
occurred in gray and white matter regions of the brain from mice subjected to cuprizone-induced 
demyelination. To this end, we compared the expression of neurosteroidogenic proteins including 
steroidogenic acute regulatory protein (StAR), voltage-dependent anion channel (VDAC), 18 Kd 
translocator protein (TSPO), and neurosteroidogenic enzymes including the side chain cleavage 
enzyme (P450scc), 3β-hydroxysteroid dehydrogenase/ isomerase (3β-HSD) and 5α-reductase (5α-R) 
during the demyelination and remyelination periods. Using immunohistochemistry and qPCR, we 
demonstrated a decreased expression of StAR, P450scc and 5α-R in consonance with an increase 
astrocytic and microglial reaction and elevated levels of TNFα during the cuprizone demyelination 
period in hippocampus, cortex and corpus callosum. These parameters as well as the glial reaction 
were normalized after two weeks of spontaneous remyelination in regions containing gray matter. 
Conversely, persistent elevated levels of TNFα and low levels of StAR and P450scc were observed 
during remyelination in corpus callosum white matter. We concluded that 
neurosteroidogenesis/myelination status and glial reactivity were inversely related in the 
hippocampus and neocortex. Establishing a cause and effect relationship for the measured variables 
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1. INTRODUCTION 
 Multiple sclerosis (MS) is a CNS disease leading to the demyelination of white and gray matter 1, 
characterized initially in most patients by relapsing-remitting episodes. MS presents loss of 
oligodendrocytes, axonal injury, neurodegeneration and inflammation 2, 3. A role for steroid 
hormones has been suggested since incidence, progression and severity of MS are affected in a sex-
dependent manner 4. Furthermore, the prospective European Pregnancy in Multiple Sclerosis 
(PRIMS) study has found that the rate of relapse is significantly reduced during the last 3 months of 
pregnancy, when circulating levels of estrogens and progesterone are highest, while the relapse rate 
increases during the first 3 months post-partum, coincident with the drop in sex steroid levels 5. 
These clinical data suggest that sex steroids might play a beneficial role in this disease. In preclinical 
model of MS, testosterone, progesterone and estradiol, exert anti-inflammatory, promyelinating and 
neuroprotective effects, reinforcing a possible therapeutic use for these hormones 6-8. In this line, we 
and others have found that progesterone administration to mice with experimental autoimmune 
encephalomyelitis (EAE), a common model for MS, reduces the clinical scores, the inflammatory 
response, prevents demyelination and axonal damage in the spinal cord 9-12. In addition to 
progesterone, treatment with estrogens reduces the clinical severity of both active and adoptive EAE 
before or after disease onset. Thus, sex steroids exert beneficial effects for MS as shown in 
numerous studies 7, 12, 13. 
It is well documented that the nervous system is capable of synthesizing de novo bioactive 
steroids from cholesterol. One or more components of neurosteroidogenesis have been found in 
neurons, oligodendrocytes, astrocytes and microglia 14-16.  The steroid synthesizing machinery 
involves the steroidogenic acute regulatory protein (StAR), which regulates cholesterol transfer 
within the mitochondria, and the transport of cholesterol via a channel composed of 18 Kd 
translocator protein (TSPO), the voltage-dependent anion channel (VDAC) plus some accessory 
proteins. Inside the mitochondria, the side chain cleavage enzyme (P450scc) converts cholesterol 
into pregnenolone, which is metabolized to progesterone by 3β-hydroxysteroid dehydrogenase/ 
isomerase (3β-HSD). Progesterone is further reduced into dihydroprogesterone (DHP) by 5α-
reductase and to allopregnanolone (ALLO) by 3α-hydroxysteroid dehydrogenase (3α-HSD) and is also 
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The neurosteroids influence growth and survival of nerve cells during development and are 
involved in the regulation of various brain and peripheral nerve functions, including behavioral, 
neuroendocrine and metabolic processes in adults 17. Therefore, altered levels of neurosteroids 
during development or in adults is associated with neurodevelopmental, psychiatric or behavioral 
disorders. In this sense, an emerging therapeutic role of steroids such as sulphated pregnanes, ALLO 
or other pharmacological strategies that enhance neurosteroidogenesis is actually considered to 
improve both emotional and cognitive behavior in neuropsychiatric disorders 18. 
Developmental myelination is also influenced by neurosteroids. ALLO is present in high 
concentrations in late gestation. Preterm birth results in the delivery of neonates with reduced 
myelination in the cerebellum and immaturity of the oligodendrocyte lineage 19. In turn, 
progesterone and its reduced metabolite ALLO stimulates myelination in organotypic cultures of rat 
cerebellum 20. Moreover, oligodendrocytes and their precursors differentially express enzymes 
needed for progesterone and its metabolites synthesis suggesting a role for these compounds in 
oligodendrocytes proliferation and differentiation during development 21. Androgens also show a 
promyelinating role since higher levels of male hormones associate with increased expression of 
myelin proteins and oligodendrocyte density in the developing corpus callosum 22.  
Literature evidence indicates that changes of neurosteroids may be involved in the 
pathophysiology of MS. Thus, the brain of MS patients and EAE animals displays reduced ALLO and 
dehydroepiandrosterone (DHEA) levels and diminished expression of their synthesizing enzymes. 
Other studies have reported that progesterone and its reduced metabolites DHP and ALLO are 
altered in CSF and plasma of EAE rats and MS patients 23, 24. Interestingly, in EAE models, reduced 
levels of neurosteroids are frequently associated with inflammation and myelin loss 25, 26, while 
exogenous administration of progesterone or synthetic progestins prevents demyelination, 
enhances myelin repair and reduces CNS inflammation 10, 27, 28. Furthermore, progesterone and the 
synthetic progestin Nestorone repair demyelinating lesions and increase oligodendrogenesis in the 
cuprizone model of MS 29.    
Previous work in the EAE model has shown that progesterone treatment   restores normal 
neurosteroidogenesis and decreases neuropathology at the spinal cord level 10, 27, 30. In view of these 
reports, the present study assessed if changes of neurosteroidogenesis also occurred in mice 
subjected to CPZ-induced demyelination. Cuprizone-treated animals are characterized by initial 
oligodendrocyte death, demyelination of neocortex, corpus callosum and hippocampus, together 
with recruitment of microglia/macrophages, astrocytes and oligodendrocyte progenitor cells (OPCs) 
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replenished and axons become remyelinated 32. To analyze events at these different periods, we 
compared the expression of neurosteroidogenic proteins and enzymes and the glial reaction after 
cuprizone-induced demyelination and during the remyelination stage. We found that 
neurosteroidogenesis/myelination status and micro/astroglial reactivity are inversely related in the 
hippocampus and neocortex, suggesting an association of enhanced neurosteroidogenesis with 
remyelination.  
 
2. MATERIALS AND METHODS 
2.1 Experimental animals and cuprizone treatment  
C57BL/6 female mice were bred and maintained in groups of five animals per cage under 
standard light conditions (12 light/dark cycles) at the facilities of the Department of Biological 
Chemistry, School of Pharmacy and Biochemistry of the University of Buenos Aires. Food and 
drinking water were given ad libitum. To induce demyelination, 8 weeks old mice were fed a 
standard powdered rodent chow mixed with 0.2% cuprizone (w/w) (bis-cyclohexanone-
oxaldihydrazone, Sigma) during 35 days (CPZ D). Spontaneous remyelination occurred when animals 
were returned to normal diet for 14 further days (CPZ R). Mice were used at day 35 (CPZ D) and 14 
days later (CPZ R). Age matched control mice received standard powdered chow without cuprizone 
(CTRL). All procedures were conducted in accordance with the recommendations set forth by the 
National Institute of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-23, 
revised 1985) and CICUAL (Institutional Committee for the Care and Use of Laboratory Animals, 
University of Buenos Aires, Argentina). All efforts were made to minimize the number of animals for 
the different experiments. 
 
2.2 Real time PCR   
For real time PCR, mice were deeply anesthetized with a mixture of xylazine (6 mg/kg i.p) and 
ketamine (75 mg/kg i.p) and killed by decapitation. Total RNA was isolated from corpus callosum, 
hippocampus and cortex using Trizol reagent (Life Technologies, Invitrogen). All samples were 
precipitated with ethanol and then dissolved in distilled water at a concentration of 1 µg/µL. Total 
RNA was subjected to Dnase 1 treatment (Promega) to remove residual contaminating genomic 
DNA. The concentration and purity of total RNA was determined by measuring the optical density at 
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using a MMLV High Performance reverse transcriptase kit (Epicentre, USA) for 60 min at 37°C in the 
presence of random hexamer primers. Table 1 shows the sequence of the forward and reverse 
primers employed for cyclophilin B, MBP, TNFα, CD11b, StAR,TSPO, VDAC, P450scc, 3β-HSD and 5α-
reductase type I as  already published 30.Cyclofilin B was used as a housekeeping gene based on the 
similarity of mRNA expression across all sample templates. Specificity of PCR amplification and the 
absence of dimers were confirmed by melting curve analysis. For amplification, 20-40 ng of cDNA 
was used and qPCR was performed under optimized conditions: 95 °C at 10 min followed by 40 
cycles at 95 °C for 0.15 s and 60°C for 1 min. Primer concentrations varied between 0.2 and 0.4 µM.  
The relative gene expression for different mRNAs was determined using Syber Green (Roche) with a 
Step One Plus System (Applied Biosystems, Foster City, CA) and data were calculated using the 2-
ΔΔctmethod 28. Results were determined as fold induction compared to controls. At least two 
replicates were analyzed per target gene for each sample. Values are expressed as mean fold-change 
± SEM, and the level of significance was set at p < 0.05. Five animals were used per experimental 
group for qPCR, composed of controls (CTRL), demyelinated (CPZ D) and remyelinated (CPZ R) mice.  
 
2.5 Histology and Immunohistochemistry  
Animals were deeply anesthetized with a mixture of xylazine (6 mg/kg i.p) and ketamine (75 mg/kg 
i.p) and perfused intracardially with 25 ml of 0.9% NaCl solution followed by 25 ml 4% 
paraformaldehyde (PFA) in 0.1 M sodium phosphate buffer (PBS) pH 7. Brains were removed, fixed 
in the same fixative for 2 h (4 °C), cryoprotected with a solution made of ethylene glycol-glycerol-0.1 
M sodium phosphate buffer pH 7.4 (0.6:0.5:1.0) overnight. After a change of the same solution, 
brains were kept frozen at −20 °C un l used. Free floating sections of 60µm were obtained with a 
vibrotome (Pelco easislicer, Ted Pella) prepared for histological techniques. For 
immunohistochemistry, sections were exposed to methanol: H2O2 (50:50) for 30 min at room 
temperature (RT) 25 °C, washed and blocked for 30 min in PBS containing 10% serum at 37 °C. 
Sections were incubated overnight with the following antibodies: monoclonal anti-MBP (1:500, 
#398212, Santa Cruz Labs), anti GFAP raised in goat (1:250, #G3893, Sigma). An anti-StAR antibody 
raised in rabbit (gift from Dr. D. Stocco, Texas Tech University, Lubbock, TX 79430, USA) was also 
used after blocking with 3% albumin. After overnight incubation at 4°C, sections were washed and 
exposed to the appropriate biotinylated anti mouse or antirabbit (1:200, Sigma) conjugated 
secondary antibody for 1 hour at RT. After a further washing step, the slides were incubated with 
Avidin/HRP-Biotin complex solution (Vectastain ABC Kit, Vector Laboratories, CA, USA) dilute 1:100 
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hydrochloride 0.25 mg/ml working solution (Diaminobenzidine,   Sigma) and 0.05% H2O2 at RT for six 
minutes after the formation of avidin-biotin-complexes. The tissue was finally dried, dehydrated and 
mounted with Permount (Fischer Scientific, Pittsburgh, PA, USA). Fluorescence 
immunohistochemistry for microglia was performed by using an anti-ionizing calcium -binding 
adapter molecule 1 (IBA 1) antibody raised in rabbit (1:1500, #019-19741,Wako, Japan) followed by 
an antirabbit secondary antibody conjugated with Alexa Fluor 488 (1:1000, Molecular Probes). 
Confocal studies for colocalization of StAR with CC1, GFAP and NeuN to label neurons were 
performed by using the previously mentioned primary antibodies for StAR, GFAP and monoclonal 
anti CC1 (1:100, #OP80, Calbiochem) and mouse anti NeuN (1:100, MAB377, Millipore) followed by 
an antimouse secondary antibody conjugated with Alexa Fluor 555 or antirabbit conjugated with 
Alexa Fluor 488 (1:1000, Molecular Probes). After washes in PBS, sections were dried at room 
temperature and coverslipped with Fluoromont-G (Southern Biotech, USA). Specificity was evaluated 
by incubating the sections without primary antibody. To determine corpus callosum demyelination, 
we employed Sudan Black histochemistry. After a wash in alcohol 70% for 5 minutes, slides were 
immersed in Sudan Black 0.5% solution for 30 minutes. After washes with water and alcohol 70%, 
sections were mounted with PBS-Glycerol 1:1 33.  
 
2.6 Microscopy and quantitative analysis 
 
We analyzed every 8th section spanning the rostrocaudal extension of the hippocampus 
corresponding to Plates 41–51 from the stereotaxic atlas of the mouse brain 34. DAB and fluorescent 
stained sections were examined and the region of interest was photographed using an Olympus BHS 
optic microscope equipped with a VT-C330N video camera or an Olympus DSU confocal microscopy 
(Tokio, Japan) equipped with the Cell Sense Dimension software, respectively. Digital images of 
corpus callosum, cortex and hippocampus were captured, taking care that every set of images were 
captured under the same light intensity and exposure time. Images were analyzed using the Optimas 
Program (Bioscan Optimas, USA) or the ImageJ Software, downloaded from the NIH website. MBP 
and Sudan Black staining was calculated by the inverse log of gray intensity per area (ILIGV/area). 
The number of astrocytes and microglial cells was calculated by counting GFAP and IBA1 positive 
cells per mm2.  StAR protein expression was calculated in Cornu ammonis (CA) 3 region of the 
hippocampus as immunoreactive (IR) area after setting a fix threshold. Four/five animals were 
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2.7 Statistical Analysis 
Group comparisons were carried out using ANOVA followed by Newman Keuls post hoc test. 
Differences were considered significant at the p<0.05 level. Statistics were performed using Prism 4 
(GraphPad Prism Software Inc., La Jolla, CA). 
 
3. RESULTS 
As already mentioned, cuprizone treatment produces demyelination of different brain 
areas, whereas spontaneous remyelination develops after removal of the toxic insult 
35. Therefore, we studied changes of neurosteroidogenic proteins and enzymes 
during demyelination and remyelination in three different brain areas: hippocampus, 
corpus callosum and cortex. The response of astrocytes, microglia and TNFα was 
also determined due to their crucial role in the pathology produced by cuprizone 
administration 36 
 
3.1 Hippocampal myelin, glial reaction and neurosteroidogenesis in CPZ D and CPZ R mice.  
Feeding cuprizone for 5 weeks significantly reduced MBP mRNA and immunoreactive protein in 
hippocampus. The ANOVA revealed groups differences (F(2,10) = 15.40; p<0.001 and F(2,8) = 24.05; 
p<0.001 respectively).Thus, MBP mRNA was reduced by 66% in CPZ D compared to control animals 
(p<0.05) (Fig. 1A) whereas densitometric measurements of immunoreactive intensity per area 
demonstrated weaker MBP signal in CPZ D mice (Fig. 1B) (p<0.05 vs. CTRL). Replacing the chelator by 
regular food for 14 days, increased MBP mRNA and MBP protein vs. CPZ D (p<0.001 for both 
measurements) (Fig 1A and B). In addition, spontaneous remyelination increased MBP mRNA levels 
and immunoreactivity of CPZ R animals to a higher level than controls (p<0.05 vs. CTRL for both 
measurements). Light microscopy images (Fig. 1C) shows the depletion of MBP in hippocampus of 
CPZ D (center image) compared to CTLR and CPZ R mice (left and right images, respectively).   
Demyelination of cuprizone-fed mice was accompanied by a strong  microgliosis of the 
whole hippocampus in the CPZ D group, as shown by quantitative analysis of a transcript and a 
histochemical marker in the stratum radiatum (Fig.1D and E). Statistical analysis by ANOVA showed 
significantly differences for CD11b mRNA (F(2,8)= 10.82; p<0.001)  and IBA1+ cells (F(2,9)= 21.96; 
p<0.001). Thus, increased expression of the microglia marker CD11b mRNA and higher number of 
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p<0.001 respectively (Fig.1D and E). Conversely, both parameters were reduced during 
remyelination (CPZ R vs. CPZ D mice: p<0.05 for CD11b mRNA and p<0.01 for IBA1+ cells) (Fig.1D and 
E). Fig. F shows higher number of microglial cells in the CPZ D group (center image) compared to 
CTLR and CPZ R mice (left and right images, respectively). In this experiment, the number of GFAP+ 
astrocytes showed significant group differences in the ANOVA test (F(2,9)= 22.55; p<0.001) and was 
markedly increased in the stratum lacunosum moleculare of the hippocampus of CPZ D vs. CTRL mice 
(p<0.001) (Fig. 1G). This glial response was linked to inflammation, as shown by a significant changes 
in TNFα (F(2,8)=35.08 p<0.0001), a main proinflammatory cytokine of activated astrocytes and 
microglia 28. Thus, in parallel to reactive gliosis, TNFα mRNA showed a three-fold induction in CPZ D 
(p<0.001) and a reduction in CPZ R mice (p<0.01 vs. CPZ D) (Fig.1H) 
After demonstrating the effectiveness of our protocol to produce demyelination and 
remyelination and changes of glial cells during these two periods, we studied neurosteroidogenesis 
by first measuring molecules belonging to the transduceosome complex. Fig. 2 shows the expression 
of StAR mRNA (Fig. 2A) and protein at the CA3 hippocampal level (B) in CTRL, CPZ D, and CPZ R mice. 
Quantitative data revealed significant group differences for STAR mRNA (F(2, 10) = p<0.001) and 
protein (F(2,9)  = 4.99 ;p<0.05) by ANOVA. StAR mRNA and the corresponding protein immunoreactive 
area (IR Area) were reduced by 30% (p<0.01) and by 50% (p<0.05) respectively, compared to CTRL. 
Subsequent remyelination restored these parameters, as CPZ R was not different from CTRL levels 
(Fig. 2A and B). Fig.2C shows low signal for immunoreactive StAR in the CA3 hippocampus region 
(CPZ D) compared to the same region of CTRL and CPZ R mice. The transduceosome molecules VDAC 
and TSPO were also evaluated at the transcriptional level. Fig.2D shows no statistical difference in 
the levels of VDAC and TSPO during the demyelination and remyelination periods. However, TSPO 
showed a trend increase in CPZ D and a trend decrease in CPZ R. These changes may be due to 
changes of microglia, since TSPO is a recognized marker of these cells. The mRNAs for P450scc and 
5α-reductase showed significantly inter group differences (F(2,10)= 6.31, p<0.05 and F(2,10)= 16.36, 
p<0.001 respectively). Both mRNAs were down-regulated by 30% during demyelination of CPZ D 
mice (Fig. 2D) (p<0.05 and p<0.001 respectively vs. CTRL) and were recovered to control levels in CPZ 
R mice (p: NS vs. CTRL). 3β-HSD mRNA showed a large intragroup variation, particularly in the 
remyelinated group, but without statistical significance.  
These results suggest that in the hippocampus, cuprizone treatment produced 
demyelination, induced a proinflammatory status (IBA 1, GFAP, TNFα) and down regulated some 
neurosteroidogenic parameters (StAR, P450scc, aromatase).   Spontaneous remyelination following 
removal of cuprizone, instead, recovered myelin formation, decreased the glial reaction and 
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3.2 Cortical myelin, glial reaction and neurosteroidogenesis in CPZ D and CPZ R mice.  
Cuprizone treatment targets myelin of several brain regions 37, 38. Therefore, we also 
determined the effectiveness of our cuprizone feeding protocol to influence myelin, glial cells and 
neurosteroidogenesis in the cerebral cortex. ANOVA results evidenced significant changes for MBP 
mRNA (F(2,9)=21.65;p<0.001) and for MBP protein (F(2,8)=20.19;p<0.001). Fig.3 shows that MBP 
transcripts (CPZ D, Fig. 3A1) and protein immunoreactivity (CPZ D, Fig. 3A2) were abruptly reduced in 
this area compared to CTRL (p<0.01 and p<0.001 respectively).  On remyelination day 14, MBP 
mRNA (CPZ R, Fig.3A1) and protein (Fig.3A2) significantly increased (p<0.001 and p<0.01 respectively 
vs. CPZ D) and were restored to CTRL levels in the case of MBP mRNA. The immunohistochemistry of 
Fig.3A shows a representative image of the demyelinated cortex of a CPZ D mouse, compared to the 
CTRL (left hand image) and the CPZ R mouse (right hand image). 
We also observed activation of glial cells in the cortex area following cuprizone intoxication. 
(ANOVA for IBA1 F(2,9)=13.72; p<0.001, GFAP F(2,9)=56.29; p<0.0001) (Fig. 3B1- B3). Thus, the number 
of IBA1+ microglial cells (Fig.3B1) and GFAP+ cells per area (Fig.3B2) were duplicated in CPZ D mice 
compared to CTRL –reductase: levels (p<0.01 and p<0.001, respectively). Simultaneously with glial 
reactivity, the levels of the proinflammatory cytokine TNFα (Fig.3B3) was also elevated in the 
demyelinated group (p<0.01 vs. CTR). Conversely, on remyelination day 14, microglia (Fig.3B1), 
astrocyte reaction (Fig.3B2) as well as the proinflammatory mediator TNFα (Fig. 3B3) were 
significantly reduced vs. CPZ D (p<0.05 for IBA1; p<0.001 for GFAP; p<0.01 for TNFα). Thus, 
spontaneous remyelination returned abnormalities of glial cells and an inflammatory marker to 
levels of CTRL mice.  
To evaluate neurosteroidogenesis in the cerebral cortex, we determined the transcripts of 
StAR, P450scc and 5α-reductase. We concentrated in these molecules because they showed 
opposite modulation in the hippocampus of CPZ D and CPZ R mice, as shown in Fig.1. The three 
parameters disclosed significant differences by ANOVA (StAR: F(2,14)=7.79,p<0.01; P450scc: 
F(2,11)=7,33,p<0.01; 5α-reductase: F(2,13)=5.31,p<0.05). In agreement with findings in the 
hippocampus, the mRNAs for StAR (Fig.3C1), P450 scc (Fig.3C2) and 5α-reductase (Fig.3C3) were 
down-regulated in the cortex during cuprizone-induced demyelination (p<0.05 vs. CTRL for the three 
transcripts). In contrast, increased mRNAs for StAR (p<0.05), P450 scc and 5α-reductase (p<0.01 for 
both) were found in remyelinated CPZ R mouse vs. CPZ D mice, reaching levels similar to those of 
CTRL mice. In the cerebral cortex, therefore, cuprizone demyelination was accompanied by 
astrogliosis, microgliosis, inflammation and decreased neurosteroidogenesis, whereas spontaneous 
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 3.3 Corpus callosum myelin, glial reaction and neurosteroidogenesis in CPZ D and CPZ R mice.  
Five weeks of cuprizone diet induced a marked demyelination of the corpus callosum, as 
shown by the decreased MBP mRNA and myelin histochemistry in CPZ D compared to CTRL mice 
(p<0.05 and p<0.01 respectively, Fig.4A1 and A2). Additionally, the density of IBA1+ cells increased 
6-fold in the CPZ D (p<0.001) (Fig.4B1) and the number of GFAP+ cells increased by 3-fold (p<0.001) 
vs. CTRL (Fig.4B2). After cuprizone withdrawal, MBP mRNA (Fig 4A1) and Sudan Black staining 
(Fig.4A2) was restored to CTRL levels (p<0.01 vs. CPZ D, NS vs. CTRL and p<0.001 vs. CPZ D, NS vs. 
CTRL; respectively). In the remyelinated corpus callosum of CPZ R mice, the number of astrocytes 
and microglia was reduced and the morphology of glial cells changed to a less reactive phenotype. 
The ANOVA test revealed significant group differences for IBA1+ cells (F(2,9)=41.32,p<0.0001) and 
GFAP+cells (F(2,9)=60.86,p<0.0001). Post-hoc comparisons showed significant changes for IBA1+ cells 
(CPZ D vs. CPZ R: p<0.001) and for GFAP + cells (CPZ D vs. CPZ R, p<0.05) (Fig.4B1 and B2). ANOVA 
results showed significant group differences for TNFα (F(2,8)=12.29,p<0.01); however, TNFα mRNA, an 
index of tissue inflammation, was increased to the same extent in CPZ D and CPZ R (p<0.001 in both 
cases vs. CTRL (Fig.4B3) 
Immunofluorescence images of IBA1 taken from the corpus callosum of CPZ D mice (Fig 4B4, 
central image), showed enhanced microglia activation compared with the neocortex and 
hippocampus. This microglia showed a globoid activated-phenotype and disposed “in chains” along 
the analyzed area. A notorious pathological response was also found for CPZ D astrocytes, which 
showed a hyperreactive phenotype bearing several GFAP+ processes (photograph not shown).  
In analogy with hippocampus and cortex, neurosteroidogenic molecules of corpus callosum 
showed a decreased expression of StAR, P450scc and 5α-reductase mRNA after cuprizone feeding. 
(ANOVA: F(2,10)=5.96,p<0.5; F(2,10)=15.28,p<0.001; F(2,9)=6.11,p<0.5, respectively). Post hoc 
comparisons showed significant differences for StAR (p<0.05), 5α-reductase (p<0.05) and P450scc 
(p<0.001) vs. CTRL (Fig.4C1-3). However, when animals switched from cuprizone to normal diet, the 
expression of these transcripts remain stable at low levels except for 5α-reductase that was 
recovered to control measurement. Thus, remyelination and decreased glial reaction of the corpus 
callosum was not accompanied by enhanced expression of all neurosteroidogenic molecules. 
Although microglial cell number decreased upon remyelination in the three analyzed areas 
(Fig.5 A-cortex, B-hippocampus and C-corpus callosum), corpus callosum microglial cells still showed 
an activated round phenotype with thick processes (Fig.5C) in contrast to arborized gray matter cells 
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neuroinflammation of the corpus callosum due to persistent high levels of TNFα by activated glial 
cells may prevent full recovery of neurosteroidogenesis. 
 
3.4  Immunostaining for StAR and markers of neurons, oligodendrocytes and astrocytes.   
Studies were also performed to determine the localization of StAR protein in control and 
treated animals. An extensive neuronal localization was demonstrated for StAR in both groups in 
hippocampus, particularly in CA3 region as previously shown in Fig. 2C. In addition, using NeuN 
staining we showed that STAR+ neurons were abundantly found in cerebral cortex (Fig.5F) while 
StAR immunoreaction in corpus callosum was scarce (not shown). GFAP labeling indicated that most 
of the reactive astrocytes found in demyelinated animals colocalized with StAR in cortex. Similar 
images were found for hippocampus and corpus callosum. Fig.5I shows the presence of GFAP/StAR 
double positive cells in cortex (arrows). Instead, colocalization with CC1 marker showed that the 
majority of oligodendrocytes were devoid of StAR protein in both groups in the three analyzed areas 
Fig.5L shows the absence of StAR immunostaining in a CC1 cell (arrow) in the cortex of a cuprizone-
treated animal.  
 
4. DISCUSSION 
Cuprizone treatment is useful to study factors involved in demyelination and remyelination, 
resembling the relapsing-remitting form of MS 39. Our results in mice subjected to cuprizone-induced 
demyelination revealed that the expression of neurosteroidogenic proteins and enzymes decreased 
in parallel with myelin loss and glial proliferation and reactivity. These parameters were restored 
during spontaneous remyelination, suggesting that remyelination and neurosteroidogenesis may be 
interconnected events at least in gray matter regions such as hippocampus and cerebral cortex.  
In the present study, the loss of myelin induced by cuprizone in the hippocampus, neocortex 
and corpus callosum was concomitant to the reduced expression of the mRNA of StAR and P450scc, 
suggesting impairment of the initial mitochondrial steps required for steroid synthesis. Interestingly, 
CPZ treatment to Swiss mice also showed lower levels of brain cholesterol among other myelin lipids 
40. Diminished expression of StAR and probably cholesterol prevents cholesterol transport, accession 
to the side chain-cleavage enzyme P450scc and conversion into pregnenolone. Furthermore, the 
microsomal enzyme 5α-reductase that reduces progesterone to dihydroprogesterone (DHP) was also 
down-regulated in the demyelinated regions. These results suggest that pregnenolone, and possibly 
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cuprizone-induced demyelination. Therefore, the induction of steroidogenic enzymes and proteins 
coincide with myelin formation and attenuation of the glial reaction observed during the 
remyelination stage.     
Regarding the mechanism involved in the abnormal steroidogenesis of cuprizone-treated 
mice, reports indicate that steroidogenic genes and proteins, such as StAR and P450 enzymes, are 
damaged by products released from reactive microglia and astrocytes 41, 42. In normal conditions, 
StAR is found in mitochondria from neurons and astrocytes 43, 44, VDAC is found predominantly in 
neuronal mitochondria 14, 45, 46, whereas P450scc is a mitochondrial-based enzyme found in neurons, 
astrocytes and oligodendrocytes 46, 47. Astrocytes are a major site for expression of 3β-HSD 
highlighting a key role of this cells type in all basic steroidogenic pathways 48. Five α-reductase type 1 
is abundantly expressed in the brain and is mainly localized in glial cells, such as astrocytes and 
oligodendrocytes 49.  
The production of steroids and the mechanisms regulating its synthesis might vary in 
different glial cells and neurons depending on different needs in health and disease. Also the 
steroidogenic activity of neurons and glia seems to be complementary. In vitro, the 5α-reductase 
activity and the 3α-HSD activity present in astrocytes are stimulated by the simultaneous presence 
of neurons 50 indicating a communication between the two populations of cells in the metabolism of 
steroid hormones. Moreover, estradiol, which can be produced by neurons, stimulates progesterone 
synthesis in astrocytes and control cellular levels of neurosteroid precursors such as DHEA and 
pregnenolone 51, 52. Therefore, down-regulation of StAR, P40scc and 5α-reductase in the 
hippocampus, neocortex and corpus callosum of CPZ D animals represents abnormalities of neurons 
and several glial cell types. Double-labeling of StAR with specific cell markers have shown intense 
colocalization with neurons and astrocytes, weak colocalization with a marker of mature 
oligodendrocytes, suggesting involvement of these cells types in changes of neurosteroidogenesis of 
CPZ D and CPZ R mice.  
An important question remains for the present investigation, i.e., the mechanisms producing 
changes in neurosteroidogenesis. It is possible that the recovery in the expression of the enzymes 
after the toxic removal, is related to lower levels of neuroinflammatory mediators considering that 
inflammatory molecules like TNFα has been associated with mitochondrial dysfunction and ROS 
production 53. Additionally, mitochondrial dysfunction also contributes to the loss of the homeostatic 
mechanism of cholesterol trafficking which has a central role in the microglial– astrocyte–neuron 
circuitry and steroid hormone synthesis 54. Thus, in this context, OPC may proliferate and 
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to astrocytes and neurons. Literature reports indicate a multifactorial regulation of this pathway as 
well. Responsible factors include the NMDA receptor, calcium influx, the pregnane-X-receptor (PXR), 
TSPO ligands and the intracellular progesterone receptor membrane component 1 (PGRCM1) 55-57. 
Liver X receptor (LXR) may be also implicated, because its activation leads to increased 
neuroprogesterone synthesis, stimulation of oligodendrocytes maturation and remyelination58.  
Neurosteroidogenesis is also modulated by the prevailing environmental conditions, such as 
peripheral nerve lesion, transient middle cerebral artery occlusion, spinal cord injury, diabetes, the 
presence of micro RNAs and EAE 25, 28, 59. Further complexity is added by ontogenetic studies, which 
show that enzymes of the neurosteroidogenic pathway are either increased (P450scc, StAR) or 
decreased (3β-HSD) 60, 61 during development. Changes closer to the cuprizone model occur during 
peripheral nerve lesion. In this case, the key enzyme of progesterone synthesis 3β-HSD shows 
changes in parallel with the regulation of peripheral myelin proteins, supporting our hypothesis for a 
role of locally synthesized neurosteroids in myelination 62. In summary, whether single or multiple 
mechanisms are set in motion for the induction of neurosteroidogenesis and myelin repair in the 
cuprizone model remains to be elucidated by future experiments.  
Our data showed that the extent of glial reaction was inversely related with myelin status 
and neurosteroidogenesis. For example, microglial cells identified by IBA1 immunoreaction and 
CD11b mRNA, as well as GFAP+ astrocytes were increased in number and adopted a reactive 
phenotype in CPZ D mice. These activated cells elicited an inflammatory response, as shown by the 
up-regulation of the inflammatory gene TNFα 28. TNFα released from reactive microglia and reactive 
astrocytes causes toxicity to neurons 63, 64, increases oligodendrocyte apoptosis 65 and decreases 
proliferation, and maturation of oligodendroglial precursor cells (OPCs) 66. In the cuprizone model, 
TNFα binding to its receptor TNFR1 is linked to demyelination67, whereas in the EAE model, TNFα 
binding TNFR1 located in astrocytes impairs synaptic connections and learning and memory in the 
hippocampus68. Cuprizone treatment also produces a prominent demyelination and perturbations of 
the hippocampal circuitry 69, in addition to demyelination of the forebrain cortex and the corpus 
callosum 70. These abnormalities may be responsible for less social interaction, decreased special 
working memory and seazures described in cuprizone treated mice 71, 72. Endogenous neurosteroids 
regulate neuronal excitability by allosteric activation of synaptic and extrasynaptic GABAA receptors 
and ALLO have been shown to have anticonvulsant properties, to modulate social performance and 
prevent memory impairment 73, 74. Therefore, altered neurosteroidogenesis in addition to other 
factors including compromised white matter and neurotransmitters system may contribute to these 
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 Notably, the hippocampus and cortex showed a strong but time limited inflammatory 
response upon demyelination. After fourteen days of cuprizone removal, the density of glial cells 
and inflammatory stimulus were restored to control levels. At this time, the mRNAs of steroidogenic 
proteins were also increased suggesting enhanced function of mitochondria and endoplasmic 
reticulum. Interestingly, MBP protein and mRNA was also recovered in the hippocampus and 
neocortex, suggesting possible myelin-protective effects of endogenous steroids. Literature reports 
have conclusively demonstrated the promyelinating, neuroprotective and antiinflammatory effects 
of sex steroids in the CNS 75, 76. In cuprizone demyelination, the combined treatment with 
progesterone and estradiol of young mice counteracts the myelin loss 77, whereas single 
progesterone treatment increases the number of mature oligodendrocytes, its precursors (OPCs) 
and myelin proteins 78. Using EAE mice, we have previously published increased expression of 
neurosteroidogenic enzymes, improved clinical signs and myelin preservation after progesterone 
treatment 30. Interestingly, mitochondrion is a target of progestin action. Pharmacological studies 
describe an increase in electron transport chain and decrease oxidative stress after exogenous 
administration of progesterone and estrogen 79, 80. Therefore, steroids may produce a “feed forward” 
mechanism stabilizing mitochondria and stimulating their own synthesis. 
Based on supporting reports, the possibility exists that the principal source of steroids 
regulating myelin and glial cells in cuprizone demyelination and remyelination phases derive from 
neurosteroidogenesis. Literature data indicates that ovariectomization does not influence the extent 
of cuprizone demyelination29. Furthermore, cuprizone treatment disrupts estrous cyclicity from the 
first week of intake and reduces uterine weight suggesting a decreased level in circulating ovarian 
hormone levels. After the removal of the quelator, normalization of the estrous cycles may take 
more than three weeks 81. Therefore, the recovery of steroidogenic enzymes and myelin after fifteen 
days may be independent on ovarian steroids.  
Cuprizone toxicity elicits an inflammatory reaction revealed by reactive gliosis and up-
regulation of pro-inflammatory cytokines such us TNFα. The latter is known to play an important role 
in oligodendrocyte death and demyelination67. Estrogens and progesterone has shown anti-
inflammatory actions by repressing DNA-binding activity of NF-κB and transcription of NF-κB 
targeted proinflammatory cytokines including TNF-α 82. Moreover, progesterone also switches 
microglial cells from a proinflammatory (M1) to an antiinflammatory (M2) phenotype in cuprizone 
demyelination 83. Therefore, our data suggest that increased neurosteroidogenesis during 
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Among the three areas analyzed, the microglial reaction, based on the number and 
morphology of the cells, was stronger in the demyelinated corpus callosum compared to the 
hippocampus or neocortex in consonance with published data 70. Although microglial density was 
dampened after cuprizone removal in the three brain regions, activated phenotype and 
proinflammatory products such as TNFα remained elevated in corpus callosum. It is possible that the 
amount of myelin debris generated following demyelination in the myelin rich corpus callosum and 
the myelin sparse grey matter may drive microglial activation in different magnitudes considering 
the very active role of these cells in cuprizone-induced demyelination 67. Therefore, it is feasible that 
normalization of inflammation requires longer times in the first region compared to hippocampus or 
cortex.   
In the cortex of control animals the density and proliferation rate of OPCs is lower compared 
to the corpus callosum 70. Here, the immunoreactivity for MBP and the amount of oligodendrocytes 
(not shown) upon cuprizone treatment and subsequent remyelination, followed the same dynamics 
in both grey and white matter structures despite obvious differences in myelination.  
 Although astrocyte proliferation was observed in the investigated brain region, it was more 
pronounced in white matter similar to microglia in coincidence with higher myelin debris during a 
demyelinating event. Interestingly, these results agree with the notion that astrocytes are 
responsible for recruitment of microglia and the latter removes myelin debris and promotes 
remyelination 84. 
In this scenario, callosal mitochondria and microsomal-based neurosteroidogenesis did not 
recover completely. The elevation in 5α-reductase expression may be due to the increase number of 
oligodendrocytes. Since this enzyme exhibited a 5-fold higher activity in oligodendrocytes, its 
elevation in corpus callosum of CPZ R might lead to high levels of the 5 alpha-reduced derivatives 
from PROG or testosterone such as 5 alpha-dihydroprogesterone (5 alpha-DHPROG) and 5 alpha-
dihydrotestosterone (5 alpha DHT) 21.  
In summary, we showed that during the remyelination period, increased 
neurosteroidogenesis plus reduced neuroneuroinflammation and glial reaction associate with 
enhanced myelin synthesis in the hippocampus and neocortex from cuprizone-treated mice. Validity 
of preclinical studies should be considered to explain events taking place in the relapsing-remitting 
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FIGURE LEGENDS 
Figure 1: Hippocampal myelin basic protein (MBP) expression and quantitative analysis of 
hippocampal glial reaction from CTRL, CPZ D and CPZ R mice .A: Level of MBP mRNA expressed as 
relative changes (mean ±SEM) with control mRNA taken as 1.0. mRNA MBP was decreased in CPZ D 
mice (*p<0.05 vs. control) and increased in the CPZ R group (*** p<0.001 vs. CPZ D; *p<0.05 vs. 
CTRL). B: MBP immunoreaction intensity was decreased in CPZ D (*p<0.05 vs. CTRL) and recovered in 
CPZ R group (***p<0.001 vs. CPZ D; *p<0.05 vs. CTRL). C: Photomicrographs taken from 
hippocampus of CTRL (left) CPZ D (middle) and CPZ R (right) showed decrease MBP immunoreaction 
in CPZ D group. Scale bar indicates 100μm. D: Level of CD11B mRNA expressed as relative changes 
(mean ±SEM) with control mRNA taken as 1.0. CD11B mRNA was increased in CPZ D mice (** p<0.01 
vs. control) and decreased in CPZ R group (*p<0.05). E: Number of IBA1+ cells/area was increased in 
CPZ D (***p<0.001 vs. CTRL) and decreased in CPZ R group (**p<0.01 vs. CPZ R; CTRL *p<0.5 vs. CPZ 
R). F: Photomicrographs taken from hippocampus of CTRL (left), CPZ D (middle) and CPZ R (right) 
showed increased IBA1+ cells density in CPZ D group. Scale bar indicates 50μm. G: Number of 
astrocytes GFAP+/mm2 was increased in CPZ D group (***p<0.001 vs. CTRL) and decreased in CPZ R 
group (*p<0.05 vs. CPZ R; CTRL **p<0.01 vs. CPZ R).H: TNFα mRNA was increased in CPZ D mice (*** 
p<0.001 vs. control) and decreased in CPZ R group (**p<0.01; CTRL **p<0.01 vs. CPZ R). Data 
obtained were analyzed by ANOVA followed by the Newman-Keuls test; n=5 animals per group. 
 
Figure 2: Hippocampal neurosteroidogenic protein and enzymes in the three experimental groups. 
A: Levels of steroidogenic acute regulatory protein (StAR) mRNA were decreased in CPZ D mice (** 
p<0.01 vs. control) and restored to CTRL levels in CPZ R group (**p<0.01 vs. CPZ D). B: StAR 
immunoreactive area in the CA3 region of the hippocampus was decreased in CPZ D and increased in 
CPZ R group (*p<0.5 vs. CPZ D; NS vs. CTRL). C: Photomicrographs taken from hippocampal CA3 
region of CTRL (left) CPZ D (middle) and CPZ R (right) showed decreased StAR immunoreactive area 
in CPZ D group. Scale bar indicates 75μm. D: mRNA levels (mean +/- SEM) of mitochondrial proteins 
and microsomal neurosteroidogenic enzymes in the hippocampus. Levels of the voltage-dependent 
anion channel  (VDAC) and translocator protein 18 K (TSPO) mRNA did not differ among CTRL, CPZ D 
and CPZ R groups although TSPO mRNA reached  higher levels in CPZ D. Levels of mRNA for 
cholesterol-side chain cleavage enzyme (P450 scc) were decreased in CPZ D (*p<0.05) and increased 
in CPZ R (*p<0.05). The last group was not different from controls (p:NS).Variations of the mRNA of 
3β-hydroxysteroid dehydrogense  (3β-HSD) did not differ significantly between control, CPZ D and 
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in CPZ R group (**p<0.01). The last group was not different from controls (p:NS).Data obtained by 
ANOVA followed by Newman-Keuls tests, n= 5 animals per group.    
 
Figure 3: Myelin, glial reaction and neurosteroidogenic parameters in the neocortex. A1: Levels of 
MBP mRNA were decreased in CPZ D mice (** p<0.01 vs. control) and increased in the CPZ R group 
(***p<0.001 vs. CPZ D; p:NS vs. CTRL). A2: Immunoreactivity for MBP was decreased in CPZ D 
(***p<0.001 vs. CTRL) and increased in CPZ R (**p<0.01; CPZ R *p<0.5 vs. CTRL). A3: 
Photomicrographs from neocortex of CTRL (left) CPZ D (middle) and CPZ R (right) showed decreased 
MBP immunoreaction in CPZ D group. Scale bar indicates 100μm. B1: Quantitative data showed 
increased number of microglial cells per mm2 in CPZ D (**p<0.01 vs. CTRL) and decreased IBA1+cells 
in CPZ R (*p<0.5: p: NS vs. CTRL). B2: The number of astrocytes GFAP+ was increased in CPZ D vs. 
CTRL (***p<0.001) and decreased in CPZ R (***p<0.001; p: NS vs. CTRL). B3: Levels of TNFα mRNA 
were increased in CPZ D mice (** p<0.01 vs. control) and decreased in CPZ R group (**p<0.01).C1-
C3: Levels of StAR, P450 scc and 5α-reductase mRNA were decreased in CPZ D mice (* p<0.05 vs. 
control) and restored to CTRL levels in CPZ R group (*p<0.05 for StAR and **p<0.01 for P450 scc and 
5α-reductase vs. CPZ D).Data obtained were analyzed by ANOVA followed by the Newman-Keuls 
test, n=5 mice per group. 
Figure 4: Myelin, glial reaction and neurosteroidogenic parameters in the corpus callosum. A1: 
Levels of MBP mRNA were decreased in CPZ D mice (* p<0.5 vs. control) and increased in the CPZ R 
group (**p<0.01 vs. CPZ D; p: NS vs. CTRL). A2: Sudan Black staining was decreased in CPZ D 
(**p<0.01 vs. CTRL) and increased in CPZ R (***p<0.001; p: NS vs. CTRL). A3: Photomicrographs from 
corpus callosum of CTRL (left) CPZ D (middle) and CPZ R (right) showed loss of myelin stained with 
Sudan Black in the CPZ D group. Scale bar: 100μm. B1: Quantitative data showed increased number 
of microglial cells / mm2 in CPZ D (***p<0.001 vs. CTRL) and decreased IBA+ cells in CPZ R 
(***p<0.001; CPZ R **p<0.01 vs. CTRL). B2: The number of astrocytes GFAP+ was increased in CPZ D 
vs. CTRL (***p<0.001) and decreased in CPZ R (*p<0.5; CPZ R ***p<0.001 vs. CTRL). B3: Levels of 
TNFα mRNA was increased in CPZ D mice (*** p<0.001 vs. control) and remained at the same level in 
CPZ R group (NS vs. CPZ D). B4:  Photomicrographs from the corpus callosum of CTRL (left), CPZ D 
(middle) and CPZ R (right) showed an intense glial reaction containing highly activated microglial 
cells in CPZ D group. Scale bar: 50μm. C1-C3: Levels of StAR, P450scc and 5α-reductase mRNA were 
decreased in CPZ D mice (*p<0.05 for StAR and 5α-reductase; ***p<0.001 for P450 scc vs. control) 
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were increased in CPZ R mice (*p<0.05 vs. CPZ D). Data obtained was analyzed by ANOVA followed 
by the Newman-Keuls test. n=5 mice per group 
Figure 5 
IBA1 immunofluorescence in brain regions and double-label immune localization of StAR with 
neuronal and glia markers. A-C: Photomicrographs of microglia in remyelinated group in neocortex, 
hippocampus and corpus callosum. 14 days after cuprizone removal, gray matter microglia adopts a 
resting state while corpus callosum microglial cells still show an activated phenotype with thick 
processes. Scale bar: 25µm. D-F: Representative confocal images of CPZ-treated mice showed 
intense NeuN/StAR colocalization in cortex. Scale bar: 20µm. G-I: In the cortex of cuprizone-treated 
mice, reactive astrocytes are double-labeled for GFAP and StAR (arrows). Scale bar: 20µm. J-L: In the 
corpus callosum of cuprizone-treated mice, CC1+ oligodendrocytes do not express StAR 
immunoreactivity. Scale bar: 20µm. 
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